RayzeBio, Inc. - 75525N107
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q4 2023
· Q3 2023
Value (USD)
Total reported value ($000)
$1.341B
QoQ value delta ($000)
+$951.9M
(+244.58%)
Implied price effect (QoQ)
+179.64%
Shares
Total shares
21,604,011
QoQ shares delta
+4,071,605
(+23.22%)
Total shares held by funds (by quarter)
Top holders (Q4 2023)
Top 25 only
Full list
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | 412,976 | 6,642,700 | 1.51% |
| WELLINGTON MANAGEMENT GROUP LLP | 215,905 | 3,504,409 | 35.69% |
| ORBIMED ADVISORS LLC | 147,045 | 2,365,213 | 2.94% |
| VANGUARD GROUP INC | 72,737 | 1,169,984 | 0.0% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 62,550 | 1,006,126 | 1.15% |
| ALLIANCEBERNSTEIN L.P. | 58,369 | 938,877 | 0.02% |
| PERCEPTIVE ADVISORS LLC | 46,257 | 744,056 | 1.03% |
| BALYASNY ASSET MANAGEMENT L.P. | 33,558 | 539,793 | 0.06% |
| Magnetar Financial LLC | 33,439 | 537,872 | 0.85% |
| Woodline Partners LP | 33,143 | 533,114 | 0.36% |
| FRANKLIN RESOURCES INC | 31,793 | 511,401 | 0.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 27,040 | 434,891 | 0.0% |
| FMR LLC | 15,248 | 245,271 | 0.0% |
| STATE STREET CORP | 13,130 | 211,205 | 0.0% |
| MORGAN STANLEY | 12,070 | 194,151 | 0.0% |
| Capital Research Global Investors | 10,619 | 170,808 | 0.0% |
| FIL Ltd | 10,071 | 162,000 | 0.01% |
| NORTHERN TRUST CORP | 10,069 | 161,975 | 0.0% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 9,147 | 147,140 | 0.0% |
| AQR Arbitrage LLC | 8,510 | 136,895 | 0.34% |
| Man Group plc | 7,460 | 120,000 | 0.02% |
| ArrowMark Colorado Holdings LLC | 7,292 | 117,306 | 0.08% |
| Blackstone Inc. | 6,719 | 108,090 | 0.03% |
| JPMORGAN CHASE & CO | 6,461 | 103,940 | 0.0% |
| UBS Group AG | 5,847 | 94,059 | 0.0% |